Compare AMRX & NG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMRX | NG |
|---|---|---|
| Founded | 2002 | 1984 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.0B |
| IPO Year | 2018 | 2002 |
| Metric | AMRX | NG |
|---|---|---|
| Price | $16.21 | $7.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $15.60 | $12.22 |
| AVG Volume (30 Days) | 1.8M | ★ 2.9M |
| Earning Date | 05-01-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 157.89 | N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.48 | N/A |
| Revenue Next Year | $7.13 | N/A |
| P/E Ratio | $84.29 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.67 | $4.05 |
| 52 Week High | $16.61 | $14.40 |
| Indicator | AMRX | NG |
|---|---|---|
| Relative Strength Index (RSI) | 78.56 | 47.38 |
| Support Level | $12.46 | $6.66 |
| Resistance Level | N/A | $10.61 |
| Average True Range (ATR) | 0.57 | 0.48 |
| MACD | 0.27 | 0.08 |
| Stochastic Oscillator | 90.29 | 53.26 |
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Novagold Resources Inc operates in the gold mining industry, focused on advancing the Donlin Gold project in Alaska. The Donlin Gold project is held by Donlin Gold LLC (Donlin Gold), a limited liability company owned equally by wholly owned subsidiaries of NOVAGOLD and Barrick Gold Corporation (Barrick). The company includes exploration and development activities of gold and other precious metals.